NCT06812260 2025-09-17A Single-arm, Open-label, Phase II Study to Evaluate Efficacy, Safety and Pharmacokinetics of HLX10 + Chemotherapy in Patients With ES-SCLCShanghai Henlius BiotechPhase 2 Recruiting26 enrolled